Stock Scorecard
Stock Summary for Bausch Health Companies Inc (BHC) - $4.62 as of 5/30/2025 6:28:43 PM EST
Total Score
9 out of 30
Safety Score
24 out of 100
Currently on the following lists
None
Tim's Recommendation
Avoid
Growth List Algorithm Criteria for BHC
| Positive earnings growth | |
| P/E ratio less than Industry P/E Ratio | |
| P/E ratio less than Sector P/E Ratio | |
| P/E ratio that is half the growth rate (or less) | |
| Positive net cash position the past year and most recent quarter | |
| Equity to debt ratio greater than 0.75 for past year and most recent quarter | |
| Positive net income past year and 12 trailing months | |
| Free cash flow ratio greater than 0 and less than 10 |
Small Cap List Algorithm Criteria for BHC
| Revenue growing by at least 20% average per year over the last 5 years | |
| Market Capitalization under 2 billion | |
| Price to Sales (P/S) ratio 12 trailing months less than Industry P/S ratio twelve trailing months | |
| Price to Sales (P/S) ratio 12 trailing months less than Sector P/S ratio twelve trailing months | |
| Net Income past year > Net Income prior year OR Net Income 12 trailing months > Net Income prior year OR Net Income 12 trailing months > Net Income past year |
Dividend List Algorithm Criteria for BHC
| Declared an ex-dividend date | |
| Forward annual dividend rate greater than 2 | |
| Positive net cash position the past year and most recent quarter | |
| Equity to debt ratio greater than 0.75 for past year and most recent quarter | |
| Current ratio most recent quarter greater than 2 | |
| Cash Flow per Share greater than Trailing Dividend Rate |
Bonus Criteria for BHC
| P/E ratio less than five-year Average P/E ratio | |
| Last Price to 52 Week Low Ratio Less Than 1 | |
| Total Cash Per Share > Last Day Price | |
| P/S Ratio < 1 | |
| P/B Ratio < 1 |
Safety Rating Criteria for BHC (24 out of 100)
| Stock Price Rating (Max of 10) | 3 |
| Historical Stock Price Rating (Max of 10) | 7 |
| Stock Price Trend (Max of 10) | 1 |
| Book Value (Max of 10) | 1 |
| Book Value to Price (Max of 10) | 0 |
| Analyst Buy Ratings (Max of 5) | 0 |
| Analyst Strong Buy Ratings (Max of 5) | 0 |
| Dividend Yield Percentage (Max of 10) | 0 |
| Operating Margin (Max of 10) | 3 |
| Trading Volume (Max of 10) | 9 |
| Price to Earnings (Max of 10) | 0 |
| Geopolitical Risk Adjustment (Always 0 for USA or a Negative Number for Non-USA) | 0 |
Latest News for for BHC
Financial Details for BHC
Company Overview |
|
|---|---|
| Ticker | BHC |
| Company Name | Bausch Health Companies Inc |
| Country | USA |
| Description | Bausch Health Companies Inc. develops, manufactures and markets a range of pharmaceutical, medical device and over-the-counter (OTC) products primarily in the therapeutic areas of eye health, gastroenterology and dermatology. The company is headquartered in Laval, Canada. |
| Sector Name | LIFE SCIENCES |
| Industry Name | PHARMACEUTICAL PREPARATIONS |
| Most Recent Quarter | 3/31/2025 |
| Next Earnings Date | 7/30/2025 |
Stock Price History |
|
| Last Day Price | 4.62 |
| Price 4 Years Ago | 27.61 |
| Last Day Price Updated | 5/30/2025 6:28:43 PM EST |
| Last Day Volume | 1,171,873 |
| Average Daily Volume | 2,048,709 |
| 52-Week High | 9.85 |
| 52-Week Low | 3.96 |
| Last Price to 52 Week Low | 16.67% |
Valuation Measures |
|
| Trailing PE | N/A |
| Industry PE | 21.58 |
| Sector PE | 40.42 |
| 5-Year Average PE | 4.79 |
| Free Cash Flow Ratio | 1.50 |
| Industry Free Cash Flow Ratio | 17.23 |
| Sector Free Cash Flow Ratio | 31.66 |
| Current Ratio Most Recent Quarter | 1.35 |
| Total Cash Per Share | 3.07 |
| Book Value Per Share Most Recent Quarter | -3.20 |
| Price to Book Ratio | 18.78 |
| Industry Price to Book Ratio | 34.25 |
| Sector Price to Book Ratio | 29.96 |
| Price to Sales Ratio Twelve Trailing Months | 0.18 |
| Industry Price to Sales Ratio Twelve Trailing Months | 150.48 |
| Sector Price to Sales Ratio Twelve Trailing Months | 40.56 |
| Analyst Buy Ratings | 0 |
| Analyst Strong Buy Ratings | 0 |
Share Statistics |
|
| Total Shares Outstanding | 369,550,000 |
| Market Capitalization | 1,707,321,000 |
| Institutional Ownership | N/A |
Dividends |
|
| Ex-Dividend Date | 11/10/2010 |
| Previous Dividend Amount | 0.0000 |
| Current Dividend Amount | 1.0000 |
| Total Years Dividend Increasing | 0 |
| Trailing Annual Dividend Rate | 0.00 |
| Trailing Annual Dividend Yield | 0.00% |
| Forward Annual Dividend Rate | 5.11 |
| Forward Annual Dividend Yield | 68.43% |
| 5-Year Dividend Payments Count | 0 |
| 3-Year Average Dividend Yield | 0.00% |
| 5-Year Average Dividend Yield | 0.00% |
| 1-Year Dividend Growth Rate Percentage | 1,328.57% |
| 3-Year Dividend Growth Rate Percentage | 149.03% |
| 5-Year Dividend Growth Rate Percentage | 27.79% |
| All-Time Dividend Growth Rate Percentage | -10.95% |
| Dividend Payout Ratio | N/A |
Income Statement |
|
| Quarterly Earnings Growth YOY | -61.20% |
| Annual Earnings Growth | 92.60% |
| Reported EPS 12 Trailing Months | -0.12 |
| Reported EPS Past Year | 0.61 |
| Reported EPS Prior Year | 2.92 |
| Net Income Twelve Trailing Months | -42,624,538 |
| Net Income Past Year | -43,791,369 |
| Net Income Prior Year | -592,000,000 |
| Quarterly Revenue Growth YOY | 4.90% |
| 5-Year Revenue Growth | 2.05% |
| Operating Margin Twelve Trailing Months | 11.90% |
Balance Sheet |
|
| Total Cash Most Recent Quarter | 1,134,000,000 |
| Total Cash Past Year | 1,181,000,000 |
| Total Cash Prior Year | 947,000,000 |
| Net Cash Position Most Recent Quarter | -20,094,000,000 |
| Net Cash Position Past Year | -17,761,000,000 |
| Long Term Debt Past Year | 18,942,000,000 |
| Long Term Debt Prior Year | 21,938,000,000 |
| Total Debt Most Recent Quarter | 21,228,000,000 |
| Equity to Debt Ratio Past Year | -0.07 |
| Equity to Debt Ratio Most Recent Quarter | -0.06 |
| Total Stockholder Equity Past Year | -1,279,000,000 |
| Total Stockholder Equity Prior Year | -1,022,000,000 |
| Total Stockholder Equity Most Recent Quarter | -1,183,000,000 |
Free Cash Flow |
|
| Free Cash Flow Twelve Trailing Months | 1,231,553,908 |
| Free Cash Flow Per Share Twelve Trailing Months | 3.33 |
| Free Cash Flow Past Year | 1,260,000,000 |
| Free Cash Flow Prior Year | 760,000,000 |
Options |
|
| Put/Call Ratio | 0.94 |
| Has Options | Options Chain |
| Liquidity Rating | |
Technical Analysis |
|
| Yahoo Finance Chart | Yahoo Finance Chart |
| MACD | -0.22 |
| MACD Signal | -0.25 |
| 20-Day Bollinger Lower Band | 3.73 |
| 20-Day Bollinger Middle Band | 6.09 |
| 20-Day Bollinger Upper Band | 8.46 |
| Beta | 0.34 |
| RSI | 39.69 |
| 50-Day SMA | 6.93 |
| 150-Day SMA | 7.45 |
| 200-Day SMA | 11.23 |
System |
|
| Modified | 5/29/2025 6:52:57 PM EST |